Grifols ADRs Tumble After Brookfield Reportedly Backs Away from Takeover Bid
Grifols' American depositary receipts slumped following a report that Brookfield Asset Management plans to abandon its acquisition of the Spanish pharmaceuticals company. The stock was down 18% at $7.14 in premarket trading. Shares had already fallen nearly 25% year-to-date when the market closed Tuesday.
For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...
Raymond James Trust N.A. reduced its holdings in Brookfield Asset Management Ltd. (NYSE:BAM – Free Report) (TSE:BAM.A) by 2.7 ...
Brookfield Asset Management's management aims to double operational metrics in five years. Read why BAM is a low-maintenance ...
Shares of Brookfield Asset Management Ltd. Cl A BAM rallied 1.19% to C$78.42 Monday, in what proved to be an otherwise ...
Brookfield Asset Management Ltd. (NYSE:BAM – Get Free Report) (TSE:BAM.A) has received a consensus rating of “Hold” ...
Connor Teskey, President of Brookfield Asset Management, stated, “We delivered record results in the third quarter, driven by the substantial increase in fee-bearing capital due to strong ...
The Spanish pharmaceutical company said it considered Brookfield’s offer of 10.50 euros a share undervalued the company and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback